These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23159231)

  • 1. Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.
    Handattu SP; Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Mishra VK; Datta G; Anantharamaiah GM
    Atherosclerosis; 2013 Mar; 227(1):58-64. PubMed ID: 23159231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
    Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM
    Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.
    Nayyar G; Handattu SP; Monroe CE; Chaddha M; Datta G; Mishra VK; Keenum TD; Palgunachari MN; Garber DW; Anantharamaiah GM
    Atherosclerosis; 2010 Dec; 213(2):449-57. PubMed ID: 21030022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.
    Handattu SP; Datta G; Epand RM; Epand RF; Palgunachari MN; Mishra VK; Monroe CE; Keenum TD; Chaddha M; Anantharamaiah GM; Garber DW
    J Lipid Res; 2010 Dec; 51(12):3491-9. PubMed ID: 20841495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2).
    Datta G; White CR; Dashti N; Chaddha M; Palgunachari MN; Gupta H; Handattu SP; Garber DW; Anantharamaiah GM
    Atherosclerosis; 2010 Jan; 208(1):134-41. PubMed ID: 19656510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques.
    Anantharamaiah GM; Garber DW; Goldberg D; Morrel E; Datta G; Palgunachari MN; Register TC; Appt SE; White CR
    J Lipid Res; 2018 Nov; 59(11):2075-2083. PubMed ID: 30201630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E mimetics and cholesterol-lowering properties.
    Sharifov OF; Nayyar G; Garber DW; Handattu SP; Mishra VK; Goldberg D; Anantharamaiah GM; Gupta H
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):371-81. PubMed ID: 22149316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo.
    Datta G; Garber DW; Chung BH; Chaddha M; Dashti N; Bradley WA; Gianturco SH; Anantharamaiah GM
    J Lipid Res; 2001 Jun; 42(6):959-66. PubMed ID: 11369804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice.
    Garber DW; Handattu S; Aslan I; Datta G; Chaddha M; Anantharamaiah GM
    Atherosclerosis; 2003 Jun; 168(2):229-37. PubMed ID: 12801605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts.
    Datta G; Chaddha M; Garber DW; Chung BH; Tytler EM; Dashti N; Bradley WA; Gianturco SH; Anantharamaiah GM
    Biochemistry; 2000 Jan; 39(1):213-20. PubMed ID: 10625496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathology.
    Handattu SP; Monroe CE; Nayyar G; Palgunachari MN; Kadish I; van Groen T; Anantharamaiah GM; Garber DW
    J Alzheimers Dis; 2013; 36(2):335-47. PubMed ID: 23603398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.
    Sharifov OF; Nayyar G; Ternovoy VV; Palgunachari MN; Garber DW; Anantharamaiah G; Gupta H
    Innate Immun; 2014 Nov; 20(8):867-80. PubMed ID: 24323453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice.
    Qin S; Kamanna VS; Lai JH; Liu T; Ganji SH; Zhang L; Bachovchin WW; Kashyap ML
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):334-43. PubMed ID: 22308547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
    Anantharamaiah GM; Garber DW; White CR
    Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing plasma cholesterol is not the end of the quest.
    Navab M; Shabihkhani M; Navab KD; Vazirian S; Haghnegahdar M; Reddy ST
    Atherosclerosis; 2013 Mar; 227(1):35-6. PubMed ID: 23343594
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ac-hE-18A-NH2 inhibits the inflammatory response induced by ox-LDL via inhibiting NF-κB activation in RAW264.7 macrophages].
    Xie Q; Li F; Zhao S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 39(3):232-8. PubMed ID: 24748185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice.
    Kawashiri M; Zhang Y; Usher D; Reilly M; Puré E; Rader DJ
    J Lipid Res; 2001 Jun; 42(6):943-50. PubMed ID: 11369802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-I Mimetic Peptides: Discordance Between In Vitro and In Vivo Properties-Brief Report.
    Ditiatkovski M; Palsson J; Chin-Dusting J; Remaley AT; Sviridov D
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1301-1306. PubMed ID: 28522696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.